The Study of Association of Helicobacter Infections in Biliary Tract Cancers
Recruiting
Observational Study
Biliary Tract Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Biliary tract carcinoma (BTC) includes gallbladder carcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma, intrahepatic cholangiocarcinoma. Chronic infections of the biliary tract are major drivers of cancer. Helicobacter species is one of the most established pro-oncogenic pathogens for gastric malignancy.
In addition to H Pylori, H.bilis and H.hepaticus have a significantly higher i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Biliary tract carcinoma patients who underwent resection
* Patients undergoing cholecystectomy for benign biliary disease.
* Voluntary healthy liver donors with no gallbladder pathology
* Patients undergoing cholecystectomy for conditions with high risk of malignancy
Exclusio…
Contacts